Autori: Halota W
| Naslov | A novel primeboost therapeutic vaccine induces sustained seroconversion at 52 weeks in patients with HBeAg+ chronic hepatitis B: a phase IIa clinical trial (Meeting Abstract) |
| Autori | Schneider J Halota W Delic Dragan S Nesic Zorica I Prokopowicz D Flisiak R Kuydowicz J Jablkowski M Cianciara J Mach T Modrzewska R Fabri Miklos Tomic Dragan V Horban A Krycka W Cripps M |
| Info | JOURNAL OF CLINICAL VIROLOGY, (2006), vol. 36 br. , Suppl. Suppl. 2, str. S30-S30 |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
     |
| Naslov | A novel primeboost therapeutic vaccine induces sustained seroconversion at 52 weeks in patients with HBeAg plus chronic hepatitis B: A phase IIa clinical trial (Meeting Abstract) |
| Autori | Schneider J Halota W Delic Dragan S Nesic Zorica I Prokopowicz D Flisiak R Kuydowicz J Jablkowski M Cianciara J Mach T Modrzewska R Fabri Miklos Tomic Dragan V Horban A Krycka W Cripps M |
| Info | JOURNAL OF HEPATOLOGY, (2006), vol. 44 br. , Suppl. Suppl. 2, str. S277-S278 |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
|
|
| Naslov | A novel primeboost immunotherapy induces high levels of HBeAg loss after 14 weeks in patients with HBeAg plus chronic hepatitis B: A phase IIA clinical trial (Meeting Abstract) |
| Autori | Halota W Delic Dragan S Nesic Zorica I Prokopowicz D Flisiak R Kuydowicz J Jablkowski I Cianciara J Mach T Modrzewska R Fabri Miklos Tomic Dragan V Horban A Krycka W Schneider J Pearce G |
| Info | HEPATOLOGY, (2005), vol. 42 br. 4, Suppl. Suppl. 1, str. 269A-270A |
| Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
|
